Yiqun Li

Chinese Academy Of Medical Sciences & Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Association between diarrhea and survival in patients with HER2-positive advanced breast cancer treated with pyrotinib-based therapy: A landmark analysis from the real-world PRETTY study.

Association between diarrhea and survival in patients with HER2-positive advanced breast cancer treated with pyrotinib-based therapy: A landmark analysis from the real-world PRETTY study.

Journal: Breast (Edinburgh, Scotland)

Published: November 28, 2025

Single-cell profiling unveils an exhaustion trajectory of ZNF683hi tissue-resident alveolar CD8+ T cells in checkpoint inhibitor pneumonitis.

Single-cell profiling unveils an exhaustion trajectory of ZNF683hi tissue-resident alveolar CD8+ T cells in checkpoint inhibitor pneumonitis.

Journal: Med (New York, N.Y.)

Published: November 17, 2025

Chemotherapy-induced liver injury in Tibetan breast cancer patients: clinical features and risk factor analysis.

Chemotherapy-induced liver injury in Tibetan breast cancer patients: clinical features and risk factor analysis.

Journal: Cancer treatment and research communications

Published: July 17, 2025

Association of quality of life in older patients with breast cancer: a cross-sectional study from China.

Association of quality of life in older patients with breast cancer: a cross-sectional study from China.

Journal: BMJ open

Published: January 20, 2025

Prevalence of Frailty and Its Impact on Quality of Life in Older Patients With Breast Cancer: A Prospective Cross-Sectional Study.

Prevalence of Frailty and Its Impact on Quality of Life in Older Patients With Breast Cancer: A Prospective Cross-Sectional Study.

Journal: Journal of clinical nursing

Published: July 14, 2024

Pyrotinib combined with metronomic etoposide in heavily pretreated HER2-positive metastatic breast cancer: a single-arm, phase II study.

Pyrotinib combined with metronomic etoposide in heavily pretreated HER2-positive metastatic breast cancer: a single-arm, phase II study.

Journal: BMC cancer

Published: March 25, 2024

Riboflavin modified carbon cloth enhances anaerobic digestion treating food waste in a pilot-scale system.

Riboflavin modified carbon cloth enhances anaerobic digestion treating food waste in a pilot-scale system.

Journal: Frontiers in bioengineering and biotechnology

Published: March 04, 2024

Real-world treatment patterns and outcomes of pyrotinib-based therapy in patients with HER2-positive advanced breast cancer (PRETTY): A nationwide, prospective, observational study.

Real-world treatment patterns and outcomes of pyrotinib-based therapy in patients with HER2-positive advanced breast cancer (PRETTY): A nationwide, prospective, observational study.

Journal: International journal of cancer

Published: March 21, 2023

Inflammatory biomarkers in assessing severity and prognosis of immune checkpoint inhibitor-associated cardiotoxicity.

Inflammatory biomarkers in assessing severity and prognosis of immune checkpoint inhibitor-associated cardiotoxicity.

Journal: ESC heart failure

Published: October 01, 2022

Immune checkpoint inhibitors-associated cardiotoxicity in immunotherapy trials on gastrointestinal cancer patients.

Immune checkpoint inhibitors-associated cardiotoxicity in immunotherapy trials on gastrointestinal cancer patients.

Journal: Chinese medical journal

Published: June 22, 2022

Drug-induced pulmonary toxicity in breast cancer patients treated with systemic therapy: a systematic literature review.

Drug-induced pulmonary toxicity in breast cancer patients treated with systemic therapy: a systematic literature review.

Journal: Expert review of anticancer therapy

Published: October 21, 2021

Real world initial palliative treatment patterns and clinical outcomes in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: A study of the National Cancer Center, China.

Real world initial palliative treatment patterns and clinical outcomes in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer: A study of the National Cancer Center, China.

Journal: Breast (Edinburgh, Scotland)

Published: September 28, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026